| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: GMNI |
| Security Type |
American Depositary Shares |
| Lead Underwriter |
SG Cowen Securities Corp |
| Days In Registration |
32 |
| Date Filed |
23-Jun-2000 |
| Form Filed | F-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Pers/Bus/Rep Svc |
| Business Description |
Commercial physical research; indentify relationships between human genes and human health and disease |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
32.35M |
| Contact |
CT Corporation System |
| Number of Employees |
80 |
|
| Original Filing Information |
| US |
| Shares Filed |
6.0M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
6.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
900.0K |
| File Amount |
$78.0M |
| File Price Range |
$14.00 - $12.00 |
| File Mid Price |
$13.00 |
Current Filing Information
(Amended 20-Jul-2000) |
|
US |
|
Shares Filed |
6.0M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
6.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$78.0M |
| · % Change from Original |
0.0 |
| File Price Range |
$14.00 - $12.00 |
| File Mid Price |
$13.00 |
|
